Patients Before Middlemen Act

Bill 119 s 882, also known as the Pharmacy Access Improvement Act, aims to make changes to Medicare Part D in order to ensure that beneficiaries have access to a wide range of pharmacies and can choose the one that best suits their needs. The bill specifically focuses on pharmacy benefit managers (PBMs), which are entities that manage prescription drug benefits for Medicare Part D plans.

Under this bill, PBMs would be required to meet certain standards in order to participate in Medicare Part D. These standards would include ensuring that beneficiaries have access to a network of pharmacies that offer competitive pricing and convenient locations. PBMs would also be required to provide transparent information about drug pricing and coverage to beneficiaries.

The goal of the Pharmacy Access Improvement Act is to increase competition among pharmacies and PBMs, ultimately leading to lower costs and better access to prescription drugs for Medicare beneficiaries. This bill is currently being considered by Congress and has the potential to have a significant impact on the way prescription drug benefits are managed under Medicare Part D.